Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Segment Reporting [Line Items] | |||||
| Rental revenues (including tenant reimbursements) | $ 62,890 | $ 62,866 | $ 131,810 | $ 134,563 | |
| Other revenues | 425 | 25 | 501 | 50 | |
| Total revenues | 63,315 | 62,891 | 132,311 | 134,613 | |
| Property expenses | (7,196) | (6,867) | (14,772) | (14,246) | |
| Depreciation and amortization expense | (18,799) | (18,500) | (37,383) | (36,891) | |
| Impairment loss on real estate | 0 | 0 | 0 | (3,527) | |
| Gain (loss) on sale of real estate, net | 11,847 | 0 | 12,269 | 0 | |
| Interest and other income | 10,752 | 1,570 | 17,083 | 3,183 | |
| Interest expense | (8,348) | (4,444) | (14,779) | (8,944) | |
| Net income | 43,852 | 26,024 | 76,661 | 57,101 | |
| General and administrative expense | 7,719 | 8,626 | 18,068 | 17,087 | |
| Preferred stock dividends | (3,187) | (878) | (5,841) | (1,659) | |
| Net income attributable to common stockholders | 40,665 | 25,146 | 70,820 | 55,442 | |
| Segment Total Assets: | 2,581,641 | 2,581,641 | $ 2,370,858 | ||
| Operating Segments | |||||
| Segment Reporting [Line Items] | |||||
| Net income | 59,067 | 38,294 | 108,311 | 81,319 | |
| Operating Segments | Cannabis Portfolio Segment: | |||||
| Segment Reporting [Line Items] | |||||
| Rental revenues (including tenant reimbursements) | 62,890 | 62,866 | 131,810 | 134,563 | |
| Other revenues | 425 | 25 | 501 | 50 | |
| Total revenues | 63,315 | 62,891 | 132,311 | 134,613 | |
| Property expenses | (7,196) | (6,867) | (14,772) | (14,246) | |
| Depreciation and amortization expense | (18,799) | (18,500) | (37,383) | (36,891) | |
| Impairment loss on real estate | 0 | 0 | 0 | (3,527) | |
| Gain (loss) on sale of real estate, net | 11,847 | 0 | 12,269 | 0 | |
| Interest and other income | 1,429 | 770 | 1,871 | 1,370 | |
| Net income | 50,596 | 38,294 | 94,296 | 81,319 | |
| Segment Total Assets: | 2,094,298 | 2,094,298 | 2,165,359 | ||
| Operating Segments | Life Science Portfolio Segment: | |||||
| Segment Reporting [Line Items] | |||||
| Interest and other income | 8,471 | 0 | 14,015 | 0 | |
| Net income | 8,471 | 0 | 14,015 | 0 | |
| Segment Total Assets: | 275,888 | 275,888 | 152,665 | ||
| Unallocated: | |||||
| Segment Reporting [Line Items] | |||||
| Interest and other income | 852 | 800 | 1,197 | 1,813 | |
| Interest expense | (8,348) | (4,444) | (14,779) | (8,944) | |
| Net income | 43,852 | 26,024 | 76,661 | 57,101 | |
| General and administrative expense | (7,719) | $ (8,626) | (18,068) | $ (17,087) | |
| Segment Total Assets: | $ 211,455 | $ 211,455 | $ 52,834 | ||
| X | ||||||||||
- Definition Net Income (Loss) Attributable To Common Stockholders, Before Participating Securities Allocation No definition available.
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The charge against earnings in the period to reduce the carrying amount of real property to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of lease cost recognized by lessee for lease contract. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue that is not accounted for under Topic 606, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|